This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Burrowing Deep for Health Care and Tech Bargains

When Lanny Thorndike researches potential investments, he burrows so deeply into the company that he could probably tell you how the Southeast sales director takes his coffee.

The co-manager of the $27 million-in-assets (CSMVX) Century Small-Cap Select fund hunts for companies with earnings growth above their peers but with stock prices cheaper than their peers. Sure, everybody wants those companies. But for Thorndike and his team, the difference is the process: a methodical, in-depth analysis of the company's profitability, growth and valuation prospects. The process also includes talking with second-tier managers, competitors and vendors to make sure the company passes muster.

If this all sounds time-consuming, it is. But it's hard to argue with the results: The fund, first offered to individuals in early 2000, has returned an average annualized 14.86% a year for the past three years. Century Small-Cap Select ranks No. 1 among all small-cap growth funds over one- and three-year periods.

In this week's 10 Questions, Thorndike discusses his investing process and the companies it unearths. He counts several health care companies among his favorites, is lightening up on financials and is starting to find some compelling tech stocks. Which ones? Read on.

1. How have you managed to turn in the performance you have during these past few years?

Blind luck. (Laughs.)

No. I'm not sure I can attribute it to any one thing other than we spend a lot of time on balance-sheet investing -- looking at return on equity and growth in book value. Those are two metrics that we focus on more than other investors. If companies can't deliver above 15% return on equity over rolling three-year periods, those generally aren't the stories that interest us.

If we can see companies that can grow book value over five-year periods, if they are mostly growing through acquisitions it's very hard to do. We adhere to a couple of metrics that most other people don't really pay attention to. We focus on how you can return an investment on the money that shareholders give companies, which, at the end of the day, is what your shareholder equity number is.

1 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs